Abstract:Spinal cord injury (SCI) and spinal infarction lead to neurological complications and eventually to paraplegia or quadriplegia. These extremely debilitating conditions are major contributors to morbidity. Our understanding of SCI has certainly increased during the last decade, but remains far from clear. SCI consists of two defined phases: the initial impact causes primary injury, which is followed by a prolonged secondary injury consisting of evolving sub-phases that may last for years. The underlying pathophysiological mechanisms driving this condition are complex. Derangement of the vasculature is a notable feature of the pathology of SCI. In particular, an important component of SCI is the ischemia-reperfusion injury (IRI) that leads to endothelial dysfunction and changes in vascular permeability. Indeed, together with endothelial cell damage and failure in homeostasis, ischemia reperfusion injury triggers full-blown inflammatory cascades arising from activation of residential innate immune cells (microglia and astrocytes) and infiltrating leukocytes (neutrophils and macrophages). These inflammatory cells release neurotoxins (proinflammatory cytokines and chemokines, free radicals, excitotoxic amino acids, nitric oxide (NO)), all of which partake in axonal and neuronal deficit. Therefore, our review considers the recent advances in SCI mechanisms, whereby it becomes clear that SCI is a heterogeneous condition. Hence, this leads towards evidence of a restorative approach based on monotherapy with multiple targets or combinatorial treatment. Moreover, from evaluation of the existing literature, it appears that there is an urgent requirement for multi-centered, randomized trials for a large patient population. These clinical studies would offer an opportunity in stratifying SCI patients at high risk and selecting appropriate, optimal therapeutic regimens for personalized medicine.

The Potential Role of Inflammation in Modulating Endogenous Hippocampal Neurogenesis After Spinal Cord Injury

Inflammation & apoptosis in spinal cord injury.

Inflammation Mediates Varying Effects in Neurogenesis: Relevance to the Pathogenesis of Brain Injury and Neurodegenerative Disorders

Potential role of hippocampal neurogenesis in spinal cord injury induced post-trauma depression

Role of inflammation in neurological damage and regeneration following spinal cord injury and its therapeutic implications

Modulating neuroinflammation through molecular, cellular and biomaterial‐based approaches to treat spinal cord injury

Brain inflammation and cognitive decline induced by spinal cord injury can be reversed by spinal cord cell transplants

Neuroinflammation and Scarring After Spinal Cord Injury: Therapeutic Roles of MSCs on Inflammation and Glial Scar

Activating Endogenous Neurogenesis for Spinal Cord Injury Repair: Recent Advances and Future Prospects

Inflammation after spinal cord injury: a review of the critical timeline of signaling cues and cellular infiltration

Inflammogenesis of Secondary Spinal Cord Injury

Current Advancements in Spinal Cord Injury Research—Glial Scar Formation and Neural Regeneration

Epigenetic modifications of inflammation in spinal cord injury

Glial-Neuronal Interactions in Pathogenesis and Treatment of Spinal Cord Injury

Microenvironments‐Modulated Biomaterials Enhance Spinal Cord Injury Therapy

Dementia, Depression, and Associated Brain Inflammatory Mechanisms after Spinal Cord Injury

The Anti-inflammation Property of Olfactory Ensheathing Cells in Neural Regeneration After Spinal Cord Injury

Glycolytic metabolism modulation on spinal neuroinflammation and vital functions following cervical spinal cord injury

Neuroinflammation and Modulation Role of Natural Products After Spinal Cord Injury

Effects of astrocytes and microglia on neuroinflammation after spinal cord injury and related immunomodulatory strategies

Spinal cord injury: molecular mechanisms and therapeutic interventions